Royal Bank Of Canada Teva Pharmaceutical Industries LTD Call Options Transaction History

Royal Bank Of Canada

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q3 2022 Nov 14, 2022	SELL	$6.86 - $11.95 $2.02 Million - $3.51 Million	-293,900 Reduced 54.51%	245,300 $1.98 Million
Q2 2022 Aug 15, 2022	BUY	$7.38 - $10.4 $3.98 Million - $5.61 Million	539,200 New	539,200 $4.06 Million

624

565M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.